- Telehealth Visits
- Insurance plan information
Laurel Hochstetler, MS
Cancer Genetics- Telehealth Visits
- Insurance plan information
Cancer Genetics & Prevention San Mateo
Laurel Hochstetler, MS
Cancer GeneticsCancer Genetics & Prevention San Mateo
- Telehealth Visits
- Insurance plan information
On this page
About me
Laurel Hochstetler is a genetic counselor who cares for patients at risk for hereditary cancers of the digestive system.
Hochstetler earned a master's degree in genetics at Yale University, followed by a master's degree in genetic counseling at Sarah Lawrence College.
Education & training
Board certification
- Certified Genetic Counselor, American Board of Genetic Counseling
Degree
- MS, Sarah Lawrence College
- MS, Yale University
My expertise
Specialties
Conditions
- Gastrointestinal (GI) Cancer
Locations
Component Name: Provider Research Listing component built but no clinical trials or publications to display
Clinical Trials query: q=health_gateway_id_ss%3A%28%223678%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%223678%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Publication%22
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.